Literature DB >> 1913832

Human neutrophil peptide defensins induce single strand DNA breaks in target cells.

J F Gera1, A Lichtenstein.   

Abstract

To investigate whether target cell DNA injury participates in cytolysis by human neutrophil defensins (HNP), we analyzed HNP-treated cells for single strand breaks by the alkaline unwinding assay and the activation of ADPribose polymerase, a DNA repair enzyme. Strand breaks and ADP-ribosylation were first detected in K562 and Raji targets 6-8 hr after incubation with HNP and increased to maximal levels by 18 hr. DNA was not degraded into nucleosome-sized fragments. To assess the impact of DNA injury on cytolysis, we increased strand breakage by coincubating targets with HNP and two inhibitors of ADPribose polymerase, 3-aminobenzamide, or nicotinamide. Concurrently with inhibiting polymerase activity and increasing DNA injury, these agents significantly enhanced HNP-mediated cytolysis. Enhancement occurred only at time points (over 6 hr) and in targets (only nucleated targets) where HNP-induced DNA injury could be occurring. These data indicate that neutrophil defensins can induce DNA injury in targets and suggest such injury may be involved in target cell death.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1913832     DOI: 10.1016/0008-8749(91)90136-y

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  14 in total

1.  Defensins impair phagocytic killing by neutrophils in biomaterial-related infection.

Authors:  S S Kaplan; R P Heine; R L Simmons
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

Review 2.  The use of therapeutic peptides to target and to kill cancer cells.

Authors:  R J Boohaker; M W Lee; P Vishnubhotla; J M Perez; A R Khaled
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 3.  Studies on anticancer activities of antimicrobial peptides.

Authors:  David W Hoskin; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2007-11-22

Review 4.  Antifungal peptides: novel therapeutic compounds against emerging pathogens.

Authors:  A J De Lucca; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

Review 5.  Convergent evolution of defensin sequence, structure and function.

Authors:  Thomas M A Shafee; Fung T Lay; Thanh Kha Phan; Marilyn A Anderson; Mark D Hulett
Journal:  Cell Mol Life Sci       Date:  2016-08-24       Impact factor: 9.261

6.  Induction of β-defensins by l-isoleucine as novel immunotherapy in experimental murine tuberculosis.

Authors:  C E Rivas-Santiago; B Rivas-Santiago; D A León; J Castañeda-Delgado; R Hernández Pando
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

7.  Antimicrobial characterization of human beta-defensin 3 derivatives.

Authors:  David M Hoover; Zhibin Wu; Kenneth Tucker; Wuyuan Lu; Jacek Lubkowski
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  Killing of endothelial cells and release of arachidonic acid. Synergistic effects among hydrogen peroxide, membrane-damaging agents, cationic substances, and proteinases and their modulation by inhibitors.

Authors:  I Ginsburg; R S Mitra; D F Gibbs; J Varani; R Kohen
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

9.  Morphology of defensin-treated Staphylococcus aureus.

Authors:  M Shimoda; K Ohki; Y Shimamoto; O Kohashi
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

Review 10.  Antimicrobial peptide defensin: identification of novel isoforms and the characterization of their physiological roles and their significance in the pathogenesis of diseases.

Authors:  Yasuhiro Yamaguchi; Yasuyoshi Ouchi
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.